DK1697340T3 - Fremgangsmåde til oprensning af (-)-D9-trans-tetrahydrocannabinol - Google Patents

Fremgangsmåde til oprensning af (-)-D9-trans-tetrahydrocannabinol

Info

Publication number
DK1697340T3
DK1697340T3 DK04806191T DK04806191T DK1697340T3 DK 1697340 T3 DK1697340 T3 DK 1697340T3 DK 04806191 T DK04806191 T DK 04806191T DK 04806191 T DK04806191 T DK 04806191T DK 1697340 T3 DK1697340 T3 DK 1697340T3
Authority
DK
Denmark
Prior art keywords
tetrahydrocannabinol
trans
purifying
sup
mobile phase
Prior art date
Application number
DK04806191T
Other languages
Danish (da)
English (en)
Inventor
John James Keenan
Albert Sanchez
Fiona Obrock Geiser
Ronald Rossi
John Michael Whelan
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Application granted granted Critical
Publication of DK1697340T3 publication Critical patent/DK1697340T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04806191T 2003-12-23 2004-12-17 Fremgangsmåde til oprensning af (-)-D9-trans-tetrahydrocannabinol DK1697340T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329635.7A GB0329635D0 (en) 2003-12-23 2003-12-23 Process for purifying trans-tetrahydrocannabinol
PCT/GB2004/005394 WO2005061480A1 (en) 2003-12-23 2004-12-17 Process for purifying (-)-δ9-trans-tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
DK1697340T3 true DK1697340T3 (da) 2009-03-02

Family

ID=30776243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04806191T DK1697340T3 (da) 2003-12-23 2004-12-17 Fremgangsmåde til oprensning af (-)-D9-trans-tetrahydrocannabinol

Country Status (13)

Country Link
US (1) US7449589B2 (enExample)
EP (1) EP1697340B1 (enExample)
JP (1) JP5566565B2 (enExample)
CN (1) CN100482657C (enExample)
AT (1) ATE412644T1 (enExample)
AU (1) AU2004303593B2 (enExample)
CA (1) CA2549399C (enExample)
DE (1) DE602004017506D1 (enExample)
DK (1) DK1697340T3 (enExample)
ES (1) ES2313118T3 (enExample)
GB (1) GB0329635D0 (enExample)
IL (1) IL176197A (enExample)
WO (1) WO2005061480A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) * 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
US8980940B2 (en) 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US8519178B2 (en) 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
EP2642982A2 (en) 2010-11-22 2013-10-02 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
CN107405314A (zh) * 2015-02-27 2017-11-28 埃布公司 包含纯化的大麻素与至少一种类黄酮、萜或矿物质的组合的组合物
US20160250270A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
EP3455213B1 (en) * 2016-05-13 2021-11-24 Symrise AG Method for purifying cannabinoid compounds via simulated moving bed chromatography
CA3034004C (en) 2016-08-29 2021-08-03 Canopy Growth Corporation Water soluble compositions comprising purified cannabinoids
US12485129B2 (en) 2016-08-29 2025-12-02 Canopy Growth Corporation Water soluble compositions comprising purified cannabinoids
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
WO2019032609A1 (en) * 2017-08-07 2019-02-14 Massachusetts Institute Of Technology SYSTEMS AND METHODS FOR SEPARATING COMPOUNDS DERIVED FROM CANNABIS BY CHROMATOGRAPHY WITH LIQUID OR SUPERCRITICAL CARBON DIOXIDE
US10307392B2 (en) 2017-10-21 2019-06-04 Alexander Kariman Compound and method for treatment of diseases and disorders
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
US10751380B2 (en) 2018-03-08 2020-08-25 Alexander Kariman Compound and method for treating spasms, inflammation and pain
US11324718B2 (en) 2018-10-09 2022-05-10 Sartorius Chromatography Equipment Method for purifying cannabinoids
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
CN111848356A (zh) * 2019-04-30 2020-10-30 黑龙江阳光工业大麻研究院 一种大麻二酚的制备方法
CA3215944A1 (en) * 2021-05-13 2022-11-17 Christopher James CORDIER Method for selective recovery of lipophilic compounds
CN114814009B (zh) * 2022-04-07 2024-06-07 国家烟草质量监督检验中心 一种同时适用于新型烟草产品中酚类化合物及尿液中酚类化合物的代谢物的分析方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403126B1 (en) * 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
US20030050334A1 (en) * 2001-04-30 2003-03-13 Murty Ram B. Process for extraction of Delta-9-Tetrahydrocannabinol and other related cannabinoids and preparation of specific strength marijuana cigarettes
GB0112752D0 (en) 2001-05-25 2001-07-18 Johnson Matthey Plc Synthesis of cannabinoids

Also Published As

Publication number Publication date
US7449589B2 (en) 2008-11-11
EP1697340B1 (en) 2008-10-29
CA2549399A1 (en) 2005-07-07
AU2004303593A1 (en) 2005-07-07
WO2005061480A1 (en) 2005-07-07
DE602004017506D1 (de) 2008-12-11
CA2549399C (en) 2012-12-04
ES2313118T3 (es) 2009-03-01
ATE412644T1 (de) 2008-11-15
EP1697340A1 (en) 2006-09-06
JP5566565B2 (ja) 2014-08-06
US20070276031A1 (en) 2007-11-29
JP2007516271A (ja) 2007-06-21
GB0329635D0 (en) 2004-01-28
IL176197A0 (en) 2006-10-05
CN100482657C (zh) 2009-04-29
AU2004303593B2 (en) 2010-12-23
IL176197A (en) 2011-04-28
CN1898230A (zh) 2007-01-17

Similar Documents

Publication Publication Date Title
GB0329635D0 (en) Process for purifying trans-tetrahydrocannabinol
DK1356863T3 (da) Fremgangsmåde til rensning af methan-holdig spildgas
GB0304576D0 (en) Protein a chromatography
DK1180544T3 (da) Fremgangsmåde til fremstilling af syntesegas
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
WO2005073732A3 (en) Lc/ms method of analyzing high molecular weight proteins
ID23272A (id) Proses untuk pembuatan hidrokarbon dari gas sintesis
AU2003249063A1 (en) Process and apparatus for the production of hydrocarbon compounds from methane
AU2002243644A1 (en) Novel methods and blends for controlling rehology and transition temperature of liquid crystals
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
ATE469165T1 (de) Synthese von oestetrol aus von oestron abgeleiteten steroiden
GB2437442A (en) Improved process for purification of 6 acetyl 4,1',6' trichlorogalactosucrose and 4,1',6' trichlorogalactosucrose by chromatography on silanized silica gel
MA26102A1 (fr) Nouveau procde de synthese industriel du ranelate de strontium et de ses hydrates.
EA200401551A1 (ru) Получение сульфинилацетамида
IS7064A (is) Aðferð til framleiðslu á essítalóprami
DK0855365T3 (da) Fremgangsmåde til fremstilling af syntesegas
CA2180283A1 (fr) Procede de fabrication du difluoromethane
BR9903274A (pt) Processo para isolar vitamina d3
ATE308573T1 (de) Explosionsfreies emulsionspolymerisationsverfahren zur herstellung von polytetrafluorethylen
ATE389264T1 (de) Anfangssynchronisationssuche in einem mobilfunksystem
FI20011327L (fi) Menetelmä kaasutuskaasun puhdistamiseksi
ATE490258T1 (de) Anwendung von zentrifugaler verteilungschromatographie zur aufreinigung von galanthamine
FR2829404B1 (fr) Appareil automatique pour la synthese de petites molecules organiques et procede de synthese mettant en oeuvre cet appareil
WO2002081078A3 (en) Solid phase synthesis supports and methods
DE50002204D1 (de) Säulenchromatographisches trennverfahren